Integra LifeSciences Holdings Corp
Fermé
SecteurSoins de santé
15.5 0.32
Résumé
Variation du prix de l'action
24h
Min
15.31
Max
15.93
Revenu | 9.2M 4.6M |
|---|---|
Ventes | 27M 419M |
BPA | 0.56 |
Marge bénéficiaire | 1.103 |
Employés | 4,427 |
EBITDA | 3M 66M |
Prochains Résultats | 29 oct. 2026 |
|---|
Capitalisation Boursière | -219M 1.3B |
|---|---|
Ouverture précédente | 15.18 |
Clôture précédente | 15.5 |
Sentiment de l'Actualité
By Acuity
50%
50%
146 / 339 Classement par Healthcare
Integra LifeSciences Holdings Corp Graphique
Les performances passées ne sont pas un indicateur fiable des résultats futurs.
Actualités Associées
Comparaison
Variation de prix
Integra LifeSciences Holdings Corp prévision
Sentiment
By Acuity
146 / 339Classement par Soins de santé
Sentiment de l'Actualité
Neutral
Volatilité
Inférieur à la moyenne
Changement du Volume d'Actualités (RCV)
Inférieur à la moyenne
Éléments financiers
Frais Généraux et Administratifs
Dépenses d'exploitation
Résultat avant impôt
Ventes
Coût des ventes
Marge brute des ventes
Charges d'intérêt sur la dette
EBITDA
Bénéfice d'exploitation
$
À Propos Integra LifeSciences Holdings Corp
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.